Inversago Pharma Archives - Inside Precision Medicine

Inside Precision Medicine Novo Nordisk Acquires Obesity Drug Developer Inversago for up to $1.075B

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room. Mutations in the TRPC5 gene can cause obesity and postpartum depression.

News & Features

Novo Nordisk Acquires Obesity Drug Developer Inversago for up to $1.075B

August 11, 2023

Related Content

Microbial Manipulation

Microbial Manipulation

Carnegie Mellon Nets $80M+ For Cell-Based Bioelectronics to Monitor and Treat Disease

Carnegie Mellon Nets $80M+ For Cell-Based Bioelectronics to Monitor and Treat Disease

New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease

New Drug Candidate Works to Inhibit Both Tau Protein “Hotspots” in Alzheimer’s Disease

Cause of Drusen-Forming Macular Degeneration Uncovered

Cause of Drusen-Forming Macular Degeneration Uncovered